Pre-programming the way forward for epilepsy
With the new model of a Vagal Nerve Stimulator (VNS), our neurology team can pre-program our epilepsy patients treatment months in advance - meaning they can visit the hospital less often.
COVID-19: Find out about our screening clinic - and note our current visitor restrictions
With the new model of a Vagal Nerve Stimulator (VNS), our neurology team can pre-program our epilepsy patients treatment months in advance - meaning they can visit the hospital less often.
Alex has suffered from epilepsy since he was 16 years old, he has up to three seizures a week, usually while he’s sleeping. Alex spent last week in our neurology clinical trials ward, the only one of its kind in Australia – to try get to the bottom of his seizures.
This year, 22-year-old Demi Lawson has not only faced a global pandemic, but a diagnosis of brain cancer, an awake craniotomy (brain surgery) – and has been learning to live with the death of her younger brother.
The Alfred has launched a world-first clinical trial to investigate whether an existing medication can be used to treat people with Rett syndrome – a rare and catastrophic neurodevelopmental disease that currently has no cure.